Page 234 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 234
Viral Hepatitis: Hepatitis B & D - Clinical (Therapy, New Compounds, Resistance) (Cont.)
YI P0659 CYTOKINE RESPONSES IN CHRONIC HEPATITIS B
PATIENTS DOSED WITH THE NUCLEIC-ACID POLYMER
REP2139-CA
Femke Stelma*, Andrew Vaillant, Louis Jansen, Marjan J. Sinnige,
Ester M. van Leeuwen, Neeltje A. Kootstra, Michel Bazinet, M. Al-
Mahtab, Hendrik W. Reesink, The Netherlands
YI P0660 A SPECIFIC KIR/HLA-C GENOTYPE IS ASSOCIATED WITH
IMMUNE ACTIVITY AND RESPONSE TO PEGINTERFERON
AND ADEFOVIR IN HBEAG-POSITIVE CHRONIC HEPATITIS
B PATIENTS
Femke Stelma*, Louis Jansen, Marjan J. Sinnige, Ester M. van Leeuwen,
Neeltje A. Kootstra, Hendrik W. Reesink, The Netherlands
YI P0661 PREDICTION OF HBEAG SEROCONVERSION IN HBEAG-
POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH
ePOSTERS ENTECAVIR USING ALT AND PLATELET COUNT: RESULTS
FROM A LARGE EUROPEAN MULTI-CENTER STUDY
Heng Chi*, Florian van Bömmel, Maria Buti, Ashley Brown,
Ivana Carey, Massimo Fasano, David Mutimer, Katja Deterding,Ye Oo,
Pauline Arends, Robert J. de Knegt, Teresa Santantonio, Tania M. Welzel,
Pierre Pradat, Jörg Petersen, Heiner Wedemeyer, Thomas Berg,
Fabien Zoulim, Bettina E. Hansen, Harry L. Janssen, The Netherlands
YI P0662 24 WEEKS OF PEGINTERFERON MAY BE AS GOOD AS 48
WEEKS IN HBEAG-POSITIVE GENOTYPE B PATIENTS WITH
AN EARLY HBSAG RESPONSE: POOLED ANALYSIS OF TWO
RANDOMIZED TRIALS
Milan J. Sonneveld*, Henry L. Chan, Jun Cheng, Teerha Piratvisuth,
Ji-Dong Jia, Edward Gane,Yun-Fan Liaw, Bettina E. Hansen, Qing Xie,
Vincent W.-S. Wong, Jin-Lin Hou, Harry L. Janssen, The Netherlands
YI P0663 FACTORS ASSOCIATED WITH NON-ADHERENCE TO
ANTIVIRAL TREATMENT FOR HEPATITIS B
Nicole Allard*, Anouk Dev, James Dwyer, Geeta Srivatsa,
Alexander Thompson, Benjamin Cowie, Australia
YI P0664 INVESTIGATION OF RESIDUALS RESPONSIBLE FOR
BINDING OF TRIAZOLO-PYRIMIDINE INHIBITORS
WITH HBSAG BASED ON MOLECULAR DOCKING AND
PHARMACOPHORE METHODS FOR DESIGNING POTENT
HBSAG INHIBITORS
Eslam Pourbasheer*, Mahdi A. Shahmohammadi, Reza Aalizadeh, Iran
234 The International Liver Congress™ 2015 • ILC Programme
YI P0659 CYTOKINE RESPONSES IN CHRONIC HEPATITIS B
PATIENTS DOSED WITH THE NUCLEIC-ACID POLYMER
REP2139-CA
Femke Stelma*, Andrew Vaillant, Louis Jansen, Marjan J. Sinnige,
Ester M. van Leeuwen, Neeltje A. Kootstra, Michel Bazinet, M. Al-
Mahtab, Hendrik W. Reesink, The Netherlands
YI P0660 A SPECIFIC KIR/HLA-C GENOTYPE IS ASSOCIATED WITH
IMMUNE ACTIVITY AND RESPONSE TO PEGINTERFERON
AND ADEFOVIR IN HBEAG-POSITIVE CHRONIC HEPATITIS
B PATIENTS
Femke Stelma*, Louis Jansen, Marjan J. Sinnige, Ester M. van Leeuwen,
Neeltje A. Kootstra, Hendrik W. Reesink, The Netherlands
YI P0661 PREDICTION OF HBEAG SEROCONVERSION IN HBEAG-
POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH
ePOSTERS ENTECAVIR USING ALT AND PLATELET COUNT: RESULTS
FROM A LARGE EUROPEAN MULTI-CENTER STUDY
Heng Chi*, Florian van Bömmel, Maria Buti, Ashley Brown,
Ivana Carey, Massimo Fasano, David Mutimer, Katja Deterding,Ye Oo,
Pauline Arends, Robert J. de Knegt, Teresa Santantonio, Tania M. Welzel,
Pierre Pradat, Jörg Petersen, Heiner Wedemeyer, Thomas Berg,
Fabien Zoulim, Bettina E. Hansen, Harry L. Janssen, The Netherlands
YI P0662 24 WEEKS OF PEGINTERFERON MAY BE AS GOOD AS 48
WEEKS IN HBEAG-POSITIVE GENOTYPE B PATIENTS WITH
AN EARLY HBSAG RESPONSE: POOLED ANALYSIS OF TWO
RANDOMIZED TRIALS
Milan J. Sonneveld*, Henry L. Chan, Jun Cheng, Teerha Piratvisuth,
Ji-Dong Jia, Edward Gane,Yun-Fan Liaw, Bettina E. Hansen, Qing Xie,
Vincent W.-S. Wong, Jin-Lin Hou, Harry L. Janssen, The Netherlands
YI P0663 FACTORS ASSOCIATED WITH NON-ADHERENCE TO
ANTIVIRAL TREATMENT FOR HEPATITIS B
Nicole Allard*, Anouk Dev, James Dwyer, Geeta Srivatsa,
Alexander Thompson, Benjamin Cowie, Australia
YI P0664 INVESTIGATION OF RESIDUALS RESPONSIBLE FOR
BINDING OF TRIAZOLO-PYRIMIDINE INHIBITORS
WITH HBSAG BASED ON MOLECULAR DOCKING AND
PHARMACOPHORE METHODS FOR DESIGNING POTENT
HBSAG INHIBITORS
Eslam Pourbasheer*, Mahdi A. Shahmohammadi, Reza Aalizadeh, Iran
234 The International Liver Congress™ 2015 • ILC Programme
